Clinical Trial Update: Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With PET

View source ↗

Summary

A clinical trial update from Fudan University shows recruiting to evaluate whether combining ctDNA analysis with PET can predict response to standard first-line…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Fudan University | Conditions: Diffuse Large B-Cell Lymphoma, DLBCL | Status: RECRUITING